China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A randomized double‑blind controlled trial of a dual orexin receptor antagonist for sleep improvement in patients with depressive episode of bipolar disorder'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600134004
Registration Time: 2026/10/10
Type: Interventional study
Primary Sponsor: Hangzhou Seventh People's Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=339987
Published by HT Digital Content Services with permission from Health Daily Digest....